| INSY Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the INSY shares outstanding history going back to 5/2/2013:
Also see: INSY Market Cap History INSY YTD Return |
As of 5/6/2019 Insys Therapeutics has 74.57 million INSY shares outstanding. Investors often track the INSY shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows INSY share count trends over time, with 29 historical shares outstanding datapoints presented, dating back to 5/2/2013.

| INSY Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the INSY shares outstanding history going back to 5/2/2013:
Also see: INSY Market Cap History INSY YTD Return |
| INSY Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
INSY Historical Shares Outstanding: +6.66% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| INSY Stock Price Chart |
| About Insys Therapeutics Inc |
| Insys Therapeutics is a commercial-stage pharmaceutical company that develops and commercializes supportive care products. Co. has two marketed product: SUBSYS®, a proprietary sublingual fentanyl spray for breakthrough cancer pain in opioid-tolerant adult patients; and SYNDROS®, a proprietary, orally administered liquid formulation of dronabinol for the treatment of Chemotherapy-induced nausea and vomiting and anorexia associated with weight loss in patients with AIDS. Co.'s other product candidates include other dronabinol line extensions and sublingual spray product candidates. We show 29 historical shares outstanding datapoints in our coverage of INSY's shares outstanding history. Understanding the changing numbers of INSY shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like INSY versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching INSY by allowing them to research INSY shares outstanding history as well as any other stock in our coverage universe. |
| INSY Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| INSY Share Performance |
| Shares Outstanding Peers |
| Insys Therapeutics (INSY) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
INTS Shares Outstanding History INVA Shares Outstanding History INVO Shares Outstanding History INZY Shares Outstanding History IOBT Shares Outstanding History ION Shares Outstanding History IONM Shares Outstanding History IONS Shares Outstanding History IOVA Shares Outstanding History IPCI Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.